Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules, 8740-8741 [2011-3174]
Download as PDF
8740
Federal Register / Vol. 76, No. 31 / Tuesday, February 15, 2011 / Notices
ET date
Trans. No.
ET req
status
01/14/2011 .............
20110440
20110389
20110446
20110404
20110424
20110447
20110450
20110454
G
G
G
G
G
G
G
G
01/18/2011 .............
01/19/2011 .............
20110456
20110455
20100756
G
G
G
20110392
20110373
20110445
20110457
20110464
20110465
20110468
20110470
20110475
20110476
20110478
20110480
20110485
20110322
20110340
20110448
20110466
20110508
20110441
20110461
20110493
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
20110501
20110337
20110471
20110473
G
G
G
G
01/12/2011 .............
01/20/2011 .............
01/21/2011 .............
01/24/2011 .............
01/25/2011 .............
01/27/2011 .............
01/28/2011 .............
01/31/2011 .............
Party name
Mr. Shivinder Mohan Singh: Landmark Partners, Inc.-CT; Mr. Shivinder Mohan Singh.
SAFRAN SA; L–1 Identity Solutions, Inc.; SAFRAN SA.
Mark West Energy Partners, L.P.; EQT Corporation; Mark West Energy Partners, L.P.
Investor AB; The NASDAQ OMX Group, Inc.; Investor AB.
Teradata Corporation; Aprimo, Inc.; Teradata Corporation.
The Coca-Cola Company; Honest Tea Inc.; The Coca-Cola Company.
Plains All American Pipeline, L.P.; SGR Holdings, L.L.C.; Plains All American Pipeline, L.P.
Warburg Pincus Private Equity X, L.P.; ReSearch Pharmaceutical Services, Inc.; Warburg Pincus
Private Equity X, L.P.
AJAG Holdco, Inc.; ACO Holding LP; AJAG Holdco, Inc.
Teledyne Technologies Incorporated; DALSA Corporation; Teledyne Technologies Incorporated.
Hartford Health Care Corporation; Central Connecticut Health Alliance, Inc.; Hartford Health Care
Corporation.
GlaxoSmithKline plc; Affiris GmbH; GlaxoSmithKline plc.
ABB Ltd; Baldor Electric Company; ABB Ltd.
Rovi Corporation; Sonic Corporation; Rovi Corporation.
John Wood Group PLC; Production Services Network, Ltd.; John Wood Group PLC.
Fairfax Financial Holdings Limited; AbitibiBowater Inc.; Fairfax Financial Holdings Limited.
Green Equity Investors V, L.P.; Jo-Ann Stores, Inc.; Green Equity Investors V, L.P.
New Generations Trust; Thomas and Dafna Kaplan; New Generations Trust.
Koch Industries, Inc.; Hawkeye Renewables, LLC; Koch Industries, Inc.
Cephalon, Inc.; Mesoblast Limited; Cephalon, Inc.
Arthur D. Levinson; Apple Inc.; Arthur D. Levinson.
iGATE Corporation; Patni Computer Systems Limited; iGATE Corporation.
Apax Europe VII–B, L.P.; iGATE Corporation; Apax Europe VII–B, L.P.
Holcim Ltd.; John Victor Lattimore, Jr.; Holcim Ltd.
BE Aerospace, Inc.; Robert Tracey; BE Aerospace, Inc.
General Mills, Inc.; Dean Foods Company; General Mills, Inc.
Prysmian S.p.A.; Draka Holding N.V.; Prysmian S.p.A.
Alfa Laval AB; Altor II Sarl; Alfa Laval AB.
Pfizer Inc.; King Pharmaceuticals, Inc.; Pfizer Inc.
Raytheon Company; Applied Signal Technology, Inc.; Raytheon Company.
Occidental Petroleum Corporation; Antonia Lophitou; Occidental Petroleum Corporation.
Wayzata Opportunities Fund II, LP.; Public Service Enteprise Group Incorporation; Wayzata Opportunities Fund II, L.P.
Hubbard Broadcasting, Inc.; Deseret Management Corporation; Hubbard Broadcasting Inc.
Cenveo, Inc.; MeadWestvaco Corporation; Cenveo, Inc.
TSRC Corporation; The Dow Chemical Company; TSRC Corporation.
TSRC Corporation; Exxon Mobil Corporation; TSRC Corporation.
FOR FURTHER INFORMATION CONTACT:
FEDERAL TRADE COMMISSION
Sandra M. Peay, Contact Representative
or Renee Chapman, Contact
Representative, Federal Trade
Commission, Premerger Notification
Office, Bureau of Competition, Room H–
303 Washington, DC 20580, (202) 326–
3100.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2011–3175 Filed 2–14–11; 8:45 am]
BILLING CODE 6750–01–M
Granting of Request for Early
Termination of the Waiting Period
Under the Premerger Notification
Rules
Section 7A of the Clayton Act, 15
U.S.C. 18a, as added by Title II of the
Hart-Scott Rodino Antitrust
Improvements Act of 1976, requires
persons contemplating certain mergers
or acquisitions to give the Federal Trade
Commission and the Assistant Attorney
General advance notice and to wait
designated periods before
consummation of such plans. Section
7A(b)(2) of the Act permits the agencies,
in individual cases, to terminate this
waiting period prior to its expiration
and requires that notice of this action be
published in the Federal Register.
The following transactions were
granted early termination—on the dates
indicated—of the waiting period
provided by law and the premerger
notification rules. The listing for each
transaction includes the transaction
number and the parties to the
transaction. The grants were made by
the Federal Trade Commission and the
Assistant Attorney General for the
Antitrust Division of the Department of
Justice. Neither agency intends to take
any action with respect to these
proposed acquisitions during the
applicable waiting period.
jdjones on DSK8KYBLC1PROD with NOTICES
EARLY TERMINATIONS GRANTED DECEMBER 20, 2010 THRU DECEMBER 31, 2010
ET date
Trans. No.
12/20/2010 .............
VerDate Mar<15>2010
20110142
20110293
20110297
20110357
15:51 Feb 14, 2011
ET req
status
G
G
G
G
Jkt 223001
Party name
McKesson Corporation; Welsh, Carson, Anderson & Stowe IX, L.P.; McKesson Corporation.
Boston Scientific Corporation; Sadra Medical, Inc.; Boston Scientific Corporation.
The NASDAQ OMX Group, Inc.; Val E. Vaden; The NASDAO OMX Group, Inc.
Oak Hill Capital Partners II, L.P.; Vantage Oncology, Inc.; Oak Hill Capital Partners II, LP.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
E:\FR\FM\15FEN1.SGM
15FEN1
Federal Register / Vol. 76, No. 31 / Tuesday, February 15, 2011 / Notices
8741
EARLY TERMINATIONS GRANTED DECEMBER 20, 2010 THRU DECEMBER 31, 2010—Continued
ET date
Trans. No.
ET req
status
12/28/2010 .............
12/29/2010 .............
12/30/2010 .............
G
G
G
G
G
G
G
G
G
20110393
20110395
20110396
20110398
20110399
20110406
20110407
20110408
12/21/2010 .............
12/23/2010 .............
12/27/2010 .............
20110358
20110372
20110378
20110379
20110384
20110377
20110304
20110318
20110391
G
G
G
G
G
G
G
G
20100854
20110394
20110402
20110385
G
G
G
G
Vantage Oncology, Inc.; Oak Hill Capital Partners II, L.P.; Vantage Oncology, Inc.
Ebro Foods S.A.; Ricegrowers Limited; Ebro Foods S.A.
Brightpoint, Inc.; The Richard Arnesen Graham Family Descendants’ Trust; Brightpoint, Inc.
Aetna, Inc.; Medicity, Inc.; Aetna, Inc.
Illinois Tool Works Inc.; Royal Dutch Shell plc; Illinois Tool Works Inc.
Helen of Troy Limited; Kaz, Inc.; Helen of Troy Limited.
Roche Holding Ltd.; Marcadia Biotech, Inc.; Roche Holding Ltd.
STG III, LP; CoreLogic, Inc.; STG III, LP.
H.I.G. Bayside Debt & LBO Fund II, L.P.; Matrixx Initiatives, Inc.; H.I.G. Bayside Debt & LBO Fund
II, L.P.
Prestige Brands Holdings, Inc.; Johnson & Johnson; Prestige Brands Holdings, Inc.
PBF Energy Company LLC; Sunoco, Inc.; PBF Energy Company LLC.
TPG VI DE AIV II, L.P.; Ashland Inc.; TPG VI DE AIV II, L.P.
Exxon Mobil Corporation; Petrohawk Energy Corporation; Exxon Mobil Corporation.
Lennox International Inc.; The Manitowoc Company, Inc.; Lennox International Inc.
Carl C. Icahn; Dynegy Inc.; Carl C. Icahn.
China Huaneng Group; Inter Gen N.V.; China Huaneng Group.
Grupo Empresarial Kaluz, S.A. de C.V.; Rockwood Holdings, Inc.; Grupo Empresarial Kaluz, S.A.
de C.V.
Keystone Holdings, LLC; Compagnie de Saint-Gobain; Keystone Holdings, LLC.
Aceto Corporation; Ronald Gold; Aceto Corporation.
M & F Worldwide Corp.; Knowledge Universe Limited LLC; M & F Worldwide Corp.
Fairfax Financial Holdings Limited; AbitibiBowater Inc.; Fairfax Financial Holdings Limited.
For Further Information Contact:
Sandra M. Peay, Contact Representative,
or Renee Chapman, Contact
Representative, Federal Trade
Commission, Premerger Notification
Office, Bureau of Competition, Room
H–303, Washington, DC 20580, (202)
326–3100.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2011–3174 Filed 2–14–11; 8:45 am]
BILLING CODE 6750–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (NTP):
Office of Liaison, Policy, and Review;
Availability of Draft NTP Technical
Reports; Request for Comments;
Announcement of a Panel Meeting To
Peer Review Draft NTP Technical
Reports
National Institute of
Environmental Health Sciences
(NIEHS); National Institutes of Health
(NIH).
ACTION: Availability of Draft Reports;
Request for Comments; and
Announcement of a Meeting
jdjones on DSK8KYBLC1PROD with NOTICES
AGENCY:
The NTP announces the
availability of draft NTP Technical
Reports (TRs; available at https://
ntp.niehs.nih.gov/go/36051) that will be
peer-reviewed by an NTP Technical
Reports Peer Review Panel at a meeting
on April 5, 2011. The meeting is open
SUMMARY:
VerDate Mar<15>2010
15:51 Feb 14, 2011
Jkt 223001
Party name
to the public with time scheduled for
oral public comment. The NTP also
invites written comments on the draft
reports (see ‘‘Request for Comments’’
below). Summary minutes from the peer
review will be posted on the NTP Web
site following the meeting.
DATES: The meeting to review the draft
NTP TRs will be held on April 5, 2011.
The draft NTP TRs should be available
for public comment by February 25,
2011. The deadline to submit written
comments is March 22, 2011, and the
deadline for pre-registration to attend
the meeting and/or provide oral
comments at the meeting is March 29,
2011.
ADDRESSES: The meeting will be held at
the Rodbell Auditorium, Rall Building,
NIEHS, 111 T. W. Alexander Drive,
Research Triangle Park, NC 27709.
Public comments and any other
correspondence on the draft TRs should
be sent to Danica Andrews, NIEHS, P.O.
Box 12233, MD K2–03, Research
Triangle Park, NC 27709, FAX: (919)
541–0295, or andrewsda@niehs.nih.gov.
Courier address: 530 Davis Drive, Room
2136, Morrisville, NC 27560. Persons
needing interpreting services in order to
attend should contact (301) 402–8180
(voice) or (301) 435–1908 (TTY).
Requests should be made at least seven
business days in advance of the
meeting.
FOR FURTHER INFORMATION CONTACT:
Danica Andrews, NTP Designated
Federal Officer, (919) 541–2595,
andrewsda@niehs.nih.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Preliminary Agenda Topics and
Availability of Meeting Materials
The agenda topic is the peer review of
the findings and conclusions of draft
NTP TRs of toxicology and
carcinogenesis studies in conventional
or genetically modified rodent models.
The preliminary agenda listing the draft
reports and electronic files (PDF) of the
draft reports should be posted on the
NTP Web site by February 25, 2011.
Any additional information, when
available, will be posted on the NTP
Web site (https://ntp.niehs.nih.gov/go/
36051) or may be requested in hardcopy
from the Designated Federal Officer (see
ADDRESSES above). Following the
meeting, summary minutes will be
prepared and made available on the
NTP Web site. Information about the
NTP testing program is found at
https://ntp.niehs.nih.gov/go/test.
Attendance and Registration
The meeting is scheduled for April 5,
2011, from 8:30 a.m. EST to
adjournment and is open to the public
with attendance limited only by the
space available. Individuals who plan to
attend are encouraged to register online
at the NTP Web site (https://
ntp.niehs.nih.gov/go/36051) by March
29, 2011, to facilitate access to the
NIEHS campus. A photo ID is required
to access the NIEHS campus. The NTP
is making plans to videocast the meeting
through the Internet at https://
www.niehs.nih.gov/news/video/live.
Registered attendees are encouraged to
access the meeting page to stay abreast
E:\FR\FM\15FEN1.SGM
15FEN1
Agencies
[Federal Register Volume 76, Number 31 (Tuesday, February 15, 2011)]
[Notices]
[Pages 8740-8741]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3174]
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
Granting of Request for Early Termination of the Waiting Period
Under the Premerger Notification Rules
Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II
of the Hart-Scott Rodino Antitrust Improvements Act of 1976, requires
persons contemplating certain mergers or acquisitions to give the
Federal Trade Commission and the Assistant Attorney General advance
notice and to wait designated periods before consummation of such
plans. Section 7A(b)(2) of the Act permits the agencies, in individual
cases, to terminate this waiting period prior to its expiration and
requires that notice of this action be published in the Federal
Register.
The following transactions were granted early termination--on the
dates indicated--of the waiting period provided by law and the
premerger notification rules. The listing for each transaction includes
the transaction number and the parties to the transaction. The grants
were made by the Federal Trade Commission and the Assistant Attorney
General for the Antitrust Division of the Department of Justice.
Neither agency intends to take any action with respect to these
proposed acquisitions during the applicable waiting period.
Early Terminations Granted December 20, 2010 Thru December 31, 2010
------------------------------------------------------------------------
ET req
ET date Trans. No. status Party name
------------------------------------------------------------------------
12/20/2010............... 20110142 G McKesson Corporation;
Welsh, Carson,
Anderson & Stowe IX,
L.P.; McKesson
Corporation.
20110293 G Boston Scientific
Corporation; Sadra
Medical, Inc.;
Boston Scientific
Corporation.
20110297 G The NASDAQ OMX Group,
Inc.; Val E. Vaden;
The NASDAO OMX
Group, Inc.
20110357 G Oak Hill Capital
Partners II, L.P.;
Vantage Oncology,
Inc.; Oak Hill
Capital Partners II,
LP.
[[Page 8741]]
20110358 G Vantage Oncology,
Inc.; Oak Hill
Capital Partners II,
L.P.; Vantage
Oncology, Inc.
20110372 G Ebro Foods S.A.;
Ricegrowers Limited;
Ebro Foods S.A.
20110378 G Brightpoint, Inc.;
The Richard Arnesen
Graham Family
Descendants' Trust;
Brightpoint, Inc.
20110379 G Aetna, Inc.;
Medicity, Inc.;
Aetna, Inc.
20110384 G Illinois Tool Works
Inc.; Royal Dutch
Shell plc; Illinois
Tool Works Inc.
12/21/2010............... 20110377 G Helen of Troy
Limited; Kaz, Inc.;
Helen of Troy
Limited.
12/23/2010............... 20110304 G Roche Holding Ltd.;
Marcadia Biotech,
Inc.; Roche Holding
Ltd.
12/27/2010............... 20110318 G STG III, LP;
CoreLogic, Inc.; STG
III, LP.
20110391 G H.I.G. Bayside Debt &
LBO Fund II, L.P.;
Matrixx Initiatives,
Inc.; H.I.G. Bayside
Debt & LBO Fund II,
L.P.
20110393 G Prestige Brands
Holdings, Inc.;
Johnson & Johnson;
Prestige Brands
Holdings, Inc.
20110395 G PBF Energy Company
LLC; Sunoco, Inc.;
PBF Energy Company
LLC.
20110396 G TPG VI DE AIV II,
L.P.; Ashland Inc.;
TPG VI DE AIV II,
L.P.
20110398 G Exxon Mobil
Corporation;
Petrohawk Energy
Corporation; Exxon
Mobil Corporation.
20110399 G Lennox International
Inc.; The Manitowoc
Company, Inc.;
Lennox International
Inc.
20110406 G Carl C. Icahn; Dynegy
Inc.; Carl C. Icahn.
20110407 G China Huaneng Group;
Inter Gen N.V.;
China Huaneng Group.
20110408 G Grupo Empresarial
Kaluz, S.A. de C.V.;
Rockwood Holdings,
Inc.; Grupo
Empresarial Kaluz,
S.A. de C.V.
12/28/2010............... 20100854 G Keystone Holdings,
LLC; Compagnie de
Saint-Gobain;
Keystone Holdings,
LLC.
20110394 G Aceto Corporation;
Ronald Gold; Aceto
Corporation.
12/29/2010............... 20110402 G M & F Worldwide
Corp.; Knowledge
Universe Limited
LLC; M & F Worldwide
Corp.
12/30/2010............... 20110385 G Fairfax Financial
Holdings Limited;
AbitibiBowater Inc.;
Fairfax Financial
Holdings Limited.
------------------------------------------------------------------------
For Further Information Contact: Sandra M. Peay, Contact
Representative, or Renee Chapman, Contact Representative, Federal Trade
Commission, Premerger Notification Office, Bureau of Competition, Room
H-303, Washington, DC 20580, (202) 326-3100.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2011-3174 Filed 2-14-11; 8:45 am]
BILLING CODE 6750-01-M